# Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

> **NCT01098747** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 335 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Novel Ibuprofen
- **DRUG:** Standard Ibuprofen
- **DRUG:** Standard Ibuprofen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01098747
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-08
- **Target enrollment:** 335 (ACTUAL)
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01098747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01098747, "Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01098747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*